The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer?
Dynamic variation of renal function and novel or old HF biomarkers (ST2, Galectin 3, NT-proBNP) and response to cardiac resynchronization therapy (CRT)
Event:
Heart Failure 2017 - 4th World Congress on Acute Heart Failure